However, in the study by X. Wang et al., FOXP3 downregulation was found in NSCLC compared with normal tissues, which was a predictor of an unfavorable tumor stage and total and overall survival [36]. The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.